SEC Form D · Amendment · filed February 9, 2017
Tarveda Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Richard C. Wooster · Watertown, MAExecAymeric S. Sallin · Watertown, MADirectorJames J. Barrett · Watertown, MADirectorFrank C. Torti · Watertown, MADirectorEdwin M. Kania · Watertown, MADirectorLeila C. Alland · Watertown, MAExecOmid C. Farokhzad · Watertown, MADirector · PromoterAndrew J. Fromkin · Watertown, MAExec · DirectorRobert S. Langer · Watertown, MADirector · PromoterDennis C. Ausiello · Watertown, MADirectorNilesh C. Kumar · Watertown, MADirectorMark Phelps · PHOENIX, AZDirectorNancy P. Carlson · Dallas, TXDirectorLee Ainslie Iii · Dallas, TXDirectorWilliam Adams · San Francisco, CADirector · PromoterMichael D. Weinberg · Dallas, TXDirectorAndrew Saltoun · San Francisco, CAExec · DirectorTheodore Haig · PHOENIX, AZDirectorJustin Jory · San Francisco, CAExecBarry Fernando · PHOENIX, AZExec · DirectorDavid Hirschfeld · PHOENIX, AZExec · Director · PromoterJohn S. Koudounis · Naperville, ILExec · Director · PromoterThomas E. Herman · Naperville, ILDirectorFreshun D. Flowers · Tuscaloosa, ALDirectorBrian A. Meyer · New York, NYDirectorThomas Shandell · Greenwich, CTDirectorDaniel Spinner · Greenwich, CTDirectorJeffrey Bisberg · Austin, TXExecGregory S. Oberholtzer · Chicago, ILDirector · PromoterElizabeth A. Dickman · Amston, CTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗